Market Research Logo

Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers and Other Cancer Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer and Other Cancers), by End User (Hospitals, Academic

Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers and Other Cancer Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer and Other Cancers), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, Diagnostic Laboratories) - Global Industry Insights, and Forecast to 2025

Report Description
Cancer biomarkers offers great opportunity in improving management of cancer patients by enhancing the efficiency of detection and efficacy of the treatment. Biomarkers of cancer includes various biochemical components such as proteins, sugars, lipids, nucleic acids, and small metabolites, cytogenetic and cytokinetic parameters, and whole tumor cells, which are found in body fluid. Increasing research and development activities in the field of cancer biomarker to develop and identify potential cancer biomarkers for early diagnosis of cancer, will lead to the growth of cancer biomarkers market, in the near future. For instance, in March 2018, a team of researchers from University of Massachusetts and Clarkson University discovered various protein such as human chorionic gonadotropin (hCG), lipoproteins, α1-chymotrypsin and α1-antitrypsin from breast milk, which can act as a potential cancer biomarker in detection of breast cancer.
Market Dynamics
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. For instance, according to the Cancer Atlas: 2017, there were an estimated 14.1 million new cancer cases in 2012. Moreover, India, China and other East and Central Asian countries accounted for nearly half of world’s new cancer cases and deaths, in 2017. Furthermore, according to the same source, by 2025, there will be an estimated 19.3 million new cancer cases and 11.4 million cancer deaths, in emerging economies. However, high cancer treatment cost and unfavorable reimbursement policies for cancer biomarker may hinder the growth of cancer biomarkers market.
Key features of the study:

  • This report provides in-depth analysis of the cancer biomarkers market and its market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global cancer biomarkers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
  • Key companies covered as a part of this study include BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
  • The global cancer biomarkers market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for cancer biomarkers market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
  • Global Cancer Biomarkers Market, By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • Global Cancer Biomarkers Market, By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • Global Cancer Biomarkers Market, By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Global Cancer Biomarkers Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Asia Pacific
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Africa
  • By Country:
  • North Africa
  • Central Africa
  • South Africa
  • By Biomarker Type:
  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers
  • By Cancer Type:
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Liver Cancer
  • Other Cancers
  • By End User:
  • Hospitals
  • Academic and Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Cancer Diagnostic Laboratories
  • Company Profiles
  • BioMerieux S.A. *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Bard1 Life Sciences Limited
  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Merck & Co., Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Biomarker Type
Market Snippet, By Cancer Type
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Recent Developments
PEST Analysis
Reimbursement Scenario
4. Global Cancer Biomarkers Market, By Biomarker Type, 2015–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Protein Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Genetic Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Other Cancer Biomarkers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
5. Global Cancer Biomarkers Market, By Cancer Type, 2015–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Prostate Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Kidney Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Liver Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Other Cancers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
6. Global Cancer Biomarkers Market, By End User, 2015–2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Academic and Cancer Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
7. Global Cancer Biomarkers Market, By Regions, 2015–2025, (US$ Million)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, By Region, 2016–2025
North America
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Biomarker Type, 2015–2025, (US$ Million)
Market Size and Forecast, By Cancer Type, 2015–2025, (US$ Million)
Market Size and Forecast, By End User, 2015–2025, (US$ Million)
Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Heat Map Analysis
Company Profiles
BioMerieux S.A.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bard1 Life Sciences Limited
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bio-Rad Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Becton, Dickinson and Company
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Qiagen N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Thermo Fisher Scientific Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 35 market data tables and 33 figures on "Cancer Biomarkers Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report